×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
📊
Experiments
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
Vision
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
Vision
Showcase
Demo
←
Home
/
Wiki
/
Mechanism: Neuropsychiatric Symptoms in Dementia
mechanism
3,218 words
KG: Neuropsychiatric Symptoms in Dementia
2026-04-01
kind:mechanism
section:mechanisms
state:published
evidence:strong
Contents
Neuropsychiatric Symptoms in Dementia
⚙
Mechanism Info
Name
Neuropsychiatric Symptoms in Dementia
Summary
Behavioral and psychological disturbances in neurodegenerative diseases including agitation, psychosis, apathy, depression, and anxiety.
Knowledge Graph
Related Hypotheses (18)
TREM2-mediated microglial tau clearance enhancement
Score: 0.68
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.71
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.73
Smartphone-Detected Motor Variability Correction
Score: 0.73
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.78
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.57
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.69
Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.55
Competitive APOE4 Domain Stabilization Peptides
Score: 0.75
Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.54
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.64
TREM2-Dependent Microglial Senescence Transition
Score: 0.92
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.71
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.67
APOE Isoform Expression Across Glial Subtypes
Score: 0.67
APOE-TREM2 Interaction Modulation
Score: 0.66
APOE Isoform Conversion Therapy
Score: 0.62
TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.60
Show 13 more
Related Analyses (30)
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Mitochondrial transfer between neurons and glia
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived
Show 25 more
Related Experiments (3)
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40
Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.40